ClinicalTrials.gg
RecruitingNCT06853106DSP-CSUpdated Feb 28, 2025

Digital Sleep Program for College Students with Insomnia

An interventional study of Waitlist control group and digital-based multimodal sleep management program in Insomnia, sponsored by Taipei Medical University. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 26 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-28.

Sponsored by Taipei Medical University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Apr 2024, registered Feb 2025).
  • Started Apr 2024; still recruiting 2 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 26 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University — 10 open to participants now, 10 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Taipei Medical University.

Planned enrollment
5th of 19
90 · median 60
Started
2024
with 1 other
No phase
19 of 21
10 open now
Registered
14th of 21
by date

Among the 21 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University, this one is the 5th largest by planned enrollment of the 19 interventional ones that give a count, is one of 2 that started in 2024, is one of 19 with no phase, and was the 14th registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

10 of the 21 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University are open now, in 2 countries. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years to 26 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University, or all of them as a file.
02

Study summary

This randomized controlled trial (RCT) study aims to evaluate the effectiveness of a digital-based multimodal sleep management program compared to a waitlist control group in improving sleep-related outcomes, including insomnia severity, daytime sleepiness, objective sleep parameters, and sleep reactivity to stress, as well as psychological health indices, such as depression, anxiety, and resilience. Additionally, this study seeks to examine the mediating role of different chronotypes in the effectiveness of the sleep intervention on the outcomes of interest.

Read the detailed description

This is a parallel-group, randomized controlled trial (RCT). 90 participants who experiencing insomnia for at least 3 months with college students will be enrolled.

Eligible participants who complete the baseline measurements will be randomly allocated to a digital-based multimodal sleep management program group (N = 45) and a waitlist control group (N = 45).

The primary outcome is insomnia severity, assessed using the Insomnia Severity Index (ISI). The secondary outcomes include daytime sleepiness, objective sleep parameters, sleep reactivity, resilience, anxiety, and depression, which will be examined using the Epworth Sleepiness Scale (ESS), a wearable sleep tracker, the Ford Insomnia Response to Stress Test (FIRST), the Brief Resilience Scale (BRS), the State-Trait Anxiety Inventory (STAI), and the Beck Depression Index II (BDI-II), respectively. Additionally, chronotype will be assessed using the Morningness-Eveningness Questionnaire (MEQ) as a moderating role to be tested in this study. All outcomes will be measured at three time points: T0 (baseline assessment), T1 (immediately after the 4-week intervention period), and T2 (4 weeks after the intervention period).

03

Conditions studied

  • Insomnia

Keywords

  • Anxiety
  • Chronotypes
  • Daytime Sleepiness
  • Depression
  • Digital-based Sleep Management
  • Insomnia
  • Resilience
  • Sleep Reactivity
  • Mindfulness-based Breathing
04

Who can participate

Ages eligible
18 Years to 26 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Registered as a full-time student
  2. Aged 18 to 26 years old
  3. Experiencing insomnia for at least three months
  4. Currently own and use a personal mobile device
  5. Ability to read and speak Chinese
  6. Not taking hypnotics, sedatives, or antidepressants
  7. Not pregnant or lactating

Exclusion criteria

Exclusion Criteria:

  1. Using a smartphone model that cannot support the app
  2. Currently using other sleep program apps
  3. Meeting a STOP-BANG score of ≥3
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Other
    Waitlist control group

    Participants in the waitlist control group will maintain their daily routines without receiving any intervention throughout the experiment.

    Other: Waitlist control group

  • Experimental
    digital-based multimodal sleep management program

    Participants in the experimental group will receive a 4-week digital-based multimodal sleep management program.

    Behavioral: digital-based multimodal sleep management program

Interventions

  • OtherWaitlist control group

    The participants in the waitlist control group will be informed that they are on a waiting list during the intervention period, serving as a no-treatment control. They will receive the sleep intervention (i.e., the digital-based sleep management program) four weeks after the intervention period is completed.

  • Behavioraldigital-based multimodal sleep management program

    The digital-based multimodal sleep management program consists of (1) sleep hygiene education, (2) sleep restriction, and (3) mindfulness breathing exercises. The program is internet-integrated and delivered via Google Meet, with 45-minute weekly sessions over four weeks. To increase participants' adherence to the sleep management program , the course instructor will request the participants to record their daily sleep diaries (time to bed, time to sleep, wake time during sleep and wake time) and sleep journals(practices of sleep hygiene, sleep restriction and mindfulness breathing exercise) in the mobile app for at least five consecutive days each week.

06

What researchers measure

Primary outcomes

  1. Insomnia Severity:The Insomnia Severity Index (ISI)

    The Insomnia Severity Index (ISI) consists of seven items that assess the current perception of the severity of three insomnia symptoms. Each item is rated on a 5-point Likert scale, with the total score ranging from 0 to 28. Higher scores indicate greater severity of insomnia.

    Time frame: T0 = baseline; T1 = immediately after intervention; T2 = 4 weeks after intervention.

Secondary outcomes

  1. Daytime Sleepiness:The Epworth Sleepiness Scale (ESS)

    The Epworth Sleepiness Scale (ESS) is a self-reported measure of daytime sleepiness, assessing the propensity to doze or fall asleep during eight common daily activities. Each situation is rated on a 4-point scale, ranging from 0 ("would never doze") to 3 ("high chance of dozing"). The total score, obtained by summing the scores of the eight items, ranges from 0 to 24, with higher scores indicating greater levels of daytime sleepiness.

    Time frame: T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention.

  2. Sleep Parameters

    The sleep parameters will be recorded using a wearable sleep tracker (oCare Wrist-Worn Pro 100, Taiwan Biophotonic Corporation, Taiwan) daily for five consecutive days both before and immediately after the intervention. The wearable device will be paired with a mobile app for data collection and analysis. The sleep parameters derived from the device include sleep onset latency (SOL), wake after sleep onset (WASO), time in bed (TIB), total sleep time (TST), and sleep efficiency (SE).

    Time frame: T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention

  3. Sleep Reactivity: The Chinese version of the Ford Insomnia Response to Stress Test (FIRST)

    The Ford Insomnia Response to Stress Test (FIRST) measures the extent to which sleep is affected by stress in individuals experiencing stressful conditions. It is a self-administered questionnaire consisting of nine questions, each rated on a 4-point scale, ranging from 1 (unlikely to happen) to 4 (very likely to happen). The total score ranges from 9 to 36, with higher scores indicating a greater degree of sleep disruption due to stress.

    Time frame: T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention

  4. Resilience: The Chinese version of the Brief Resilience Scale (BRS)

    The Brief Resilience Scale (BRS) consists of six questions, each rated on a 5-point Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree). Questions 1, 3, and 5 are forward-scored, while questions 2, 4, and 6 are reverse-scored. The total score ranges from 5 to 25, with higher scores indicating greater resilience, reflecting an individual's ability to adapt and recover from adverse events.

    Time frame: T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention

  5. Depression: The Beck Depression Index II (BDI II)

    The Beck Depression Inventory-II (BDI-II) is a 21-item questionnaire designed to assess depressive symptoms. Response options range from 0 (did not feel it) to 3 (most or almost all the time). The total score ranges from 0 to 63, with higher scores indicating greater severity of depressive symptoms.

    Time frame: T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention

  6. Anxiety: The State Trait Anxiety Inventory (STAI)

    The State-Trait Anxiety Inventory (STAI) is a self-report scale used to assess anxiety symptoms. It consists of 40 items, divided into two distinct dimensions: trait anxiety (20 items) and state anxiety (20 items). Each item is rated on a 4-point Likert scale, ranging from "almost never" to "almost always", with higher scores indicating greater levels of anxiety.

    Time frame: T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention

Other outcomes

  1. Chronotype: The Chinese version of the Morningness-Eveningness Questionnaire (MEQ)

    The Morningness-Eveningness Questionnaire (MEQ) is a self-administered questionnaire consisting of 19 questions that assess an individual's preferred bedtime, wake-up time, and activity time. Responses are scored on a Likert-type scale, with total scores ranging from 16 to 86, reflecting differences in circadian rhythms. Higher scores indicate a stronger tendency to be a morning-type individual.

    Time frame: T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention

07

Study locations

1 of 1 sites recruiting
  • Taipei Medicine University
    Taipei, 11031, Taiwan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Feb 2027, 34 months after the start.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 34 months is above that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 20, 2025
First posted
Feb 28, 2025
StartActual
Apr 24, 2024
Primary completionEst.
Feb 28, 2027
CompletionEst.
Jul 31, 2027
Last update
Feb 28, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06853106
Collaborators
National Science and Technology Council of Taiwan
Responsible party
Pei-Shan, Tsai (Principal Investigator, Taipei Medical University) — Principal investigator
First posted
Feb 28, 2025
Start date
Apr 24, 2024
Primary completion
Feb 28, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Feb 28, 2025

Study contacts

Pei-Shan Tsai, PhD
Contact
ptsai@tmu.edu.tw
+886227361661 ext. 6321

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion